Clinical Study for Bupi Qingfei Decoction on Reducing Recurrent Attack of Pseudomonas aeruginosa Colonized Bronchiectasis

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Outpatient or inpatient patients who meet the diagnostic criteria of PA-colonized bronchiectasis;
•2. Aged 18-70 years old;
•3. Patients with lung-qi deficiency and phlegm-heat accumulation in TCM syndrome differentiation;
•4. Patients with acute exacerbation at least once in the past year;
•5. Those who are willing to follow the doctor's diagnosis and treatment arrangements and sign the informed consent.

•1. Those who do not meet the above criteria for diagnosis and differentiation of TCM syndrome;
•2. Pregnant or lactating women;
•3. History of chronic alcoholism or drug abuse or any factors affecting compliance;
•4. Low compliance during screening period;
•5. Complications with cardiovascular diseases (such as acute myocardial infarction, heart failure, etc.), cerebrovascular diseases (such as cerebral infarction, cerebral hemorrhage), liver diseases (such as viral hepatitis, cirrhosis, etc.). Primary diseases such as kidney (such as glomerulonephritis, nephrotic syndrome, etc.) and hematopoietic system (such as leukemia, hematopoietic dysfunction, etc.);
•6. Liver and kidney dysfunction: abnormal liver (ALT or AST) more than double the upper limit of normal value or abnormal renal function (BUN or Cr);
•7. Psychiatric patients;
•8. allergic constitution and allergic to this drug;
•9. Hemoptysis is the main cause of bronchiectasis those who want to perform;
•10. those who have participated in other clinical trials in 1 months;
•11. Other situations that the researchers think are not suitable for selection.

发起方

Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine